Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Achilles Therapeutics Plc (ACHL)

Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Achilles Therapeutics plc Announces Transfer of ADS Listing to Nasdaq Capital Market Quiver Quantitative, Inc. - Tue Nov 19, 2024

Achilles Therapeutics' ADSs will transfer to Nasdaq Capital Market, extending compliance period for minimum bid price requirement.Quiver AI SummaryAchilles Therapeutics plc announced the approval from...

ACHL : 1.4800 (+0.68%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Thu Sep 21, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

JAZZ : 242.84 (-1.22%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.5550 (-1.68%)
ALXO : 1.9900 (+2.58%)
GNPX : 4.80 (-1.54%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Wed Sep 20, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

JAZZ : 242.84 (-1.22%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.5550 (-1.68%)
ALXO : 1.9900 (+2.58%)
GNPX : 4.80 (-1.54%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation FinancialNewsMedia - Wed Sep 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

JAZZ : 242.84 (-1.22%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.5550 (-1.68%)
ALXO : 1.9900 (+2.58%)
GNPX : 4.80 (-1.54%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the...

JAZZ : 242.84 (-1.22%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.5550 (-1.68%)
ALXO : 1.9900 (+2.58%)
GNPX : 4.80 (-1.54%)

Barchart Exclusives

NFLX Stock Alert: What to Know as Bill Ackman Takes Stake in Netflix Barchart - 11 minutes ago
Bill Ackman reveals a sizable stake in NFLX stock. But does that warrant investing in NFLX shares today? Let’s find out! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.